Cargando…
Regulatory and Operational Complexities of Conducting a Clinical Treatment Trial During an Ebola Virus Disease Epidemic
The first phase II and III clinical trials for Ebola virus disease treatments were conducted during the West Africa outbreak. We report the operational practicalities of conducting a phase II clinical trial of TKM-130803 to international standards during this outbreak.
Autores principales: | Rojek, Amanda M, Dunning, Jake, Leliogdowicz, Aleksandra, Castle, Lyndsey, Van Lieshout, Mary, Carson, Gail, Sahr, Foday, Olliaro, Piero, Horby, Peter W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905621/ https://www.ncbi.nlm.nih.gov/pubmed/29206908 http://dx.doi.org/10.1093/cid/cix1061 |
Ejemplares similares
-
Experimental Treatment of Ebola Virus Disease with Brincidofovir
por: Dunning, Jake, et al.
Publicado: (2016) -
Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial
por: Dunning, Jake, et al.
Publicado: (2016) -
Monkeypox: how will we know if the treatments work?
por: Rojek, Amanda, et al.
Publicado: (2022) -
Pharmacokinetics of TKM-130803 in Sierra Leonean patients with Ebola virus disease: plasma concentrations exceed target levels, with drug accumulation in the most severe patients
por: Scott, Janet T., et al.
Publicado: (2020) -
Offering patients more: how the West Africa Ebola outbreak can shape innovation in therapeutic research for emerging and epidemic infections
por: Rojek, Amanda M., et al.
Publicado: (2017)